none title certification

MB "Nanopharma" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

Financial statement report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2022
0
-
-167
-167
-
-
-
4,417
3,737
0
8,154
2023
0
-
-356
-356
-
-
-
4,061
4,521
0
8,582
2024
0
-
-83
-83
-
-
-
3,978
4,521
0
8,499
unlock data icon

Register and

explore Okredo data
unlock data icon

Register and

explore Okredo data

2024

Turnover (€)

0 €Ascended- *

Sales per employee (€)

-

Profit before tax (€)

-83 €Ascended77 % *

Net Profit (€)

-83 €Ascended77 % *

Profit per employee (€)

-

Total profitability (%)

-

Net profitability (%)

-

Equity (€)

3,978 €Descended-2 % *

Amounts Payable And Liabilities (€)

4,521 €Ascended0 % *

Non-current Assets (€)

0 €Ascended- *

CurrentAssets (€)

8,499 €Descended-1 % *

*over the last year starting selected period